Expanded Prostate Cancer Study of Anti-Androgen Drug Signals Hope

patientpower has 2398 videos Subscribe Here

Description: Dr. Raymond Lance, a urologic oncologist with Eastern Virginia Medical School, explains the new treatment options for men with metastatic castration-resistant prostate cancer. He reviews the approved treatment, Enzalutamide, an androgen receptor inhibitor that has shown significant increase in survival for men who failed therapy. Dr. Lance discusses the STRIVE Study and TERRAIN Study, clinical trials that continue to explore the potential use of this therapy. Dr. Lance also touches on other therapeutic options and expresses optimism about treatment for patients with this disease.
Shared By : patientpower
Posted on : 04/05/13
Added : 5 years ago
Category : Prostate Cancer